期刊文献+

升降散对脓毒症小鼠CD4^+、CD8^+T细胞的影响 被引量:10

Effect of “Shengjiang Powder”on CD4^+ and CD8^+ in mice with sepsis
原文传递
导出
摘要 目的观察升降散对脓毒症小鼠脾细胞中CD4+、CD8+T细胞的影响。方法雄性Balb/c小鼠84只,按随机数字表法分为正常组、假手术组、脓毒症组、升降散组,各组又分为6 h、12 h和24 h 3个时间点亚组。除正常组外,其余各组采用盲肠结扎穿孔术(CLP)制备脓毒症小鼠模型。各组在造模前72 h开始灌胃给药或0.9%Na Cl溶液,术后按各个时间点采用流式细胞仪方法检测小鼠脾细胞中CD4+、CD8+T细胞占淋巴细胞百分比。结果与脓毒症组相比,升降散组可显著上调CLP后6 h及12 h的CD4+水平,下调CLP后6 h及12 h的CD8+水平,差异均有统计学意义(P<0.05)。结论升降散可以纠正脓毒症初期小鼠的细胞免疫功能紊乱,具有免疫调节作用。 Objective To investigate the effect of "Shengjiang Powder" to the CD4 ^+ , CD8^ + T cells in the spleen ceils of sepsis mice. Methods SPF level male mice were enrolled and the models were established by cecel ligation puncture (CLP). Eighty-four healthy Balb/c mice were divided into normal group, sham operation group, sepsis group and "Shengjiang Powder" group by random number table, and each group was divided into subgroups of 6h, 12h, 24h. Seventy-two hours before modeling, mice were fed with 0.9% NaCl by intragastric administration. After operation, we detected the proportion of CD4^+、CD8^+、 T ceils in the leukomonocyte by flow cytometry. Results Compared with sepsis group, "Shengjiang Powder" could up-regulate the CD4 ^+ T cell level of 6 hours and 12 hours significantly and down-regulate the CD8^ + T cell level of 6 hours and 12 hours statistically ( P 〈 0.05 ). Conclusion "Shengjiang Powder" can regulate the dysfunction of cellular immune.
出处 《上海中医药杂志》 2014年第11期78-81,共4页 Shanghai Journal of Traditional Chinese Medicine
基金 上海市教委资助项目(zzszy12041)
关键词 升降散 脓毒症 CD4^+T细胞 CD8^+T细胞 细胞免疫 "Shengjiang Powder" sepsis CD4 ^+T cell CD8 ^+T cell cellular immunity
  • 相关文献

参考文献14

  • 1Gaieski DF, Edwards JM, Kallan M J, et al. Benchmarking the incidence and mortality of severe sepsis in the United States [ J ]. Crit Care Med, 2013,41 (5) :1167-1174.
  • 2Rittirsch D, Huber-Lang MS, Flierl MA, et al. Immunodesign of experimental sepsis by cecal ligation and puncture [ J ]. Nat Protoc, 2009, 4 (1) : 31-36.
  • 3Bagshaw SM, Uchino S, Belomo R, et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes[ J]. Clin J Am Soc Nephrul, 2007, 2(3) : 431-439.
  • 4De Backer D, Aldecoa C, Njimi H ,et al. Dopamina versus norepinephrine in the treatment of septic shoek : a meta- analysis [ J ]. Crit care Meal, 2012,40(3) :725-730.
  • 5Brahmamdam P, Inoue S, Unsinger J, et al. Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis[ J]. J Leukoc Biol,2010, 88(2) :233-240.
  • 6Huang X, Venet F, Wang YL, et al. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis[ J]. Proc Natl Acad Sci USA,2009,106 (15) :6303-6308.
  • 7尹明,沈洪.治疗细菌感染的新思路[J].中国危重病急救医学,2012,24(3):132-134. 被引量:9
  • 8Pepper M, Jenkins MK. Origins of CD4( + ) effector and central memory T cells[J]. Nat Immunol,2011,12(6) :467-471.
  • 9Janssen EM, Droin NM, Lemmens EE, et al. CD4^+ T-cell help controls CD8^+ T-cell memory via TRAIL-mediated activation-induced cell death [J]. Nature,2005 434 (7029) : 88-93.
  • 10Sacks JA, Bevan MJ. TRAIL deficiency does not rescue impaired CD8^+ T cell memory generated in the absence of CD4^+ T cell help [ J ]. Immuno1,2008,180 ( 7 ) :4570-4576.

二级参考文献62

共引文献362

同被引文献172

引证文献10

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部